Indusviva Healthsciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.00 M
as on 16-12-2024
- Revenue -58.70%
(FY 2022)
- Profit -99.38%
(FY 2022)
- Ebitda -102.80%
(FY 2022)
- Net Worth 1.50%
(FY 2022)
- Total Assets 12.77%
(FY 2022)
About Indusviva Healthsciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹6.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jestin Joy, Renny Mathew, and Mandalanen Subramanyam serve as directors at the Company.
- CIN/LLPIN
U15100KA2014PTC073082
- Company No.
073082
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Indusviva Healthsciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jestin Joy  | Director | 12-Jul-2021 | Current |
| Renny Mathew | Director | 12-Jul-2021 | Current |
| Mandalanen Subramanyam | Director | 26-Jul-2018 | Current |
Financial Performance of Indusviva Healthsciences.
Indusviva Healthsciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 58.7% decrease. The company also saw a substantial fall in profitability, with a 99.38% decrease in profit. The company's net worth moved up by a moderate rise of 1.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indusviva Healthsciences?
In 2022, Indusviva Healthsciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Indusviva Phytochemicals Private LimitedActive 4 years 3 months
Mandalanen Subramanyam is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 23 Oct 2020 | ₹6.00 M | Satisfied |
How Many Employees Work at Indusviva Healthsciences?
Indusviva Healthsciences has a workforce of 118 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indusviva Healthsciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indusviva Healthsciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
